Page last updated: 2024-11-04

terazosin and Anasarca

terazosin has been researched along with Anasarca in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Research Excerpts

ExcerptRelevanceReference
"Terazosin is an alpha1-selective adrenoceptor blocking agent that has been reported in many clinical trials to be an effective choice for the treatment of benign prostatic hyperplasia (BPH)."9.12Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan. ( Lan, SK; Ou, JH; Tsai, YS; Tzai, TS, 2007)
"Terazosin is an alpha1-selective adrenoceptor blocking agent that has been reported in many clinical trials to be an effective choice for the treatment of benign prostatic hyperplasia (BPH)."5.12Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan. ( Lan, SK; Ou, JH; Tsai, YS; Tzai, TS, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, YS1
Lan, SK1
Ou, JH1
Tzai, TS1

Trials

1 trial available for terazosin and Anasarca

ArticleYear
Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Clinical therapeutics, 2007, Volume: 29, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Dizziness; Drugs, Generic; Edema;

2007